Gene Page: GOLGA3
Summary ?
| GeneID | 2802 |
| Symbol | GOLGA3 |
| Synonyms | GCP170|MEA-2 |
| Description | golgin A3 |
| Reference | MIM:602581|HGNC:HGNC:4426|Ensembl:ENSG00000090615|HPRD:03990|Vega:OTTHUMG00000168023 |
| Gene type | protein-coding |
| Map location | 12q24.33 |
| Pascal p-value | 0.035 |
| Sherlock p-value | 0.594 |
Gene in Data Sources
| Gene set name | Method of gene set | Description | Info |
|---|---|---|---|
| CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
| Top 10 positively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| CA14 | 0.71 | 0.68 |
| AGA | 0.61 | 0.58 |
| LASS2 | 0.61 | 0.56 |
| TF | 0.60 | 0.65 |
| GLTP | 0.60 | 0.64 |
| HSPA2 | 0.60 | 0.69 |
| RHOG | 0.60 | 0.62 |
| ELOVL1 | 0.59 | 0.63 |
| GJB1 | 0.59 | 0.60 |
| LITAF | 0.59 | 0.52 |
| Top 10 negatively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| MYC | -0.38 | -0.37 |
| TES | -0.37 | -0.42 |
| TMC2 | -0.36 | -0.41 |
| PNPLA3 | -0.36 | -0.33 |
| SCUBE1 | -0.36 | -0.37 |
| COTL1 | -0.36 | -0.33 |
| AC110814.1 | -0.36 | -0.31 |
| IDH1 | -0.35 | -0.39 |
| VASH2 | -0.35 | -0.35 |
| SRGAP1 | -0.35 | -0.34 |
Section V. Pathway annotation
| Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
|---|---|---|---|
| SENESE HDAC3 TARGETS DN | 536 | 332 | All SZGR 2.0 genes in this pathway |
| NUYTTEN NIPP1 TARGETS DN | 848 | 527 | All SZGR 2.0 genes in this pathway |
| FUJIWARA PARK2 IN LIVER CANCER UP | 8 | 7 | All SZGR 2.0 genes in this pathway |
| NIKOLSKY BREAST CANCER 12Q24 AMPLICON | 15 | 7 | All SZGR 2.0 genes in this pathway |
| IIZUKA LIVER CANCER PROGRESSION L1 G1 DN | 12 | 6 | All SZGR 2.0 genes in this pathway |
| KAYO CALORIE RESTRICTION MUSCLE DN | 87 | 59 | All SZGR 2.0 genes in this pathway |
| CUI TCF21 TARGETS 2 DN | 830 | 547 | All SZGR 2.0 genes in this pathway |
| BLALOCK ALZHEIMERS DISEASE UP | 1691 | 1088 | All SZGR 2.0 genes in this pathway |
| DOUGLAS BMI1 TARGETS DN | 314 | 188 | All SZGR 2.0 genes in this pathway |
| CREIGHTON ENDOCRINE THERAPY RESISTANCE 5 | 482 | 296 | All SZGR 2.0 genes in this pathway |
| FOSTER TOLERANT MACROPHAGE DN | 409 | 268 | All SZGR 2.0 genes in this pathway |
| PURBEY TARGETS OF CTBP1 NOT SATB1 UP | 344 | 215 | All SZGR 2.0 genes in this pathway |
| RATTENBACHER BOUND BY CELF1 | 467 | 251 | All SZGR 2.0 genes in this pathway |